| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website https://www.jocmr.org |
Letter to the Editor
Volume 15, Number 4, April 2023, pages 250-254
Post-COVID-19 Cholangiopathy: A Recent Indication for Liver Transplantation
Table
| Parameter | Group A (liver transplantation) | Group B (non-liver transplantation) |
|---|---|---|
| DM: diabetes mellitus; LFTs: liver function tests; HPL: hyperlipidemia; HTN: hypertension; PCC: post-COVID-19 cholangiopathy. | ||
| Number of patients | 4 | 26 |
| Median age (years) | 52 | 53 |
| Comorbid diseases | ||
| Obesity | 2 | 7 |
| HTN | 2 | 12 |
| HPL | 2 | 6 |
| DM | 1 | 5 |
| Male percentage | 100% | 80% |
| Initial LFTs | Normal in 50% | Abnormal in 100% |
| Initial bilirubin levels | Within normal range | Within normal range |
| Histopathological findings | Severe and diffuse degenerative changes, marked fibrosis | Mild-moderate degenerative changes, mild fibrosis |